Serum midkine as a biomarker for malignancy, prognosis, and chemosensitivity in head and neck squamous cell carcinoma

Improved therapies for individuals with head and neck squamous cell carcinoma (HNSCC) may be developed by identification of appropriate biomarkers. The aim of this study was to evaluate the usefulness of serum midkine measurement as a biomarker for HNSCC. Pretreatment serum midkine concentrations we...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer Med
Main Authors: Yamashita, Taku, Shimada, Hideaki, Tanaka, Shingo, Araki, Koji, Tomifuji, Masayuki, Mizokami, Daisuke, Tanaka, Nobuaki, Kamide, Daisuke, Miyagawa, Yoshihiro, Suzuki, Hiroshi, Tanaka, Yuya, Shiotani, Akihiro
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2016
Assuntos:
Clinical Cancer Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4799940/
https://ncbi.nlm.nih.gov/pubmed/26798989
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.600
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares